EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
93 hedge funds and large institutions have $122M invested in Eiger BioPharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
56% less capital invested
Capital invested by funds: $275M → $122M (-$153M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $78K
Holders
93
Holding in Top 10
3
Calls
–
Puts
$78K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$2.84M | |
| 3 | +$2.55M | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$1.47M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.36M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$7.11M | |
| 3 | -$6.7M | |
| 4 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$3.04M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.39M |